Savitz Adam 4
4 · Alto Neuroscience, Inc. · Filed Jul 11, 2024
Insider Transaction Report
Form 4
Savitz Adam
CHIEF MEDICAL OFFICER
Transactions
- Purchase
Common Stock
2024-07-09$12.53/sh+10,681$133,833→ 35,532 total(indirect: By Trust) - Purchase
Common Stock
2024-07-10$13.22/sh+2,931$38,748→ 39,851 total(indirect: By Trust) - Purchase
Common Stock
2024-07-09$13.15/sh+1,388$18,252→ 36,920 total(indirect: By Trust)
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.05 to $13.04 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]The shares are directly held by Robert L. Friedman 2003 Long-Term Trust fbo Lisa Savitz (the "Friedman Trust"). The spouse of the Reporting Person is the beneficiary of the Friedman Trust, and the Reporting Person may be deemed to share beneficial ownership of the securities held by the Friedman Trust.
- [F3]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.04 to $13.30 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.